Nastech

Seattle biotech entrepreneur floating $15M IPO

Veteran Seattle biotech player Steven Quay wants to fund his diagnostic testing company, Atossa Genetics, through a $15 million IPO. No underwriters are signed on yet, though. Quay is the former CEO of Sonus and Nastech, explains Xconomy, neither of which have fared well....
Get Adobe Flash playerPlugin by wpburn.com wordpress themes